IP Library Granted Patent US 11,952,608
Granted Patent B2
US 11,952,608 · App. 17/141,758 · Granted Apr 9, 2024

Methods for production of oxygenated terpenes

Inventors: Ajikumar Parayil Kumaran (Watertown, MA); Chin Giaw Lim (Cambridge, MA); Liwei Li (Cambridge, MA); Souvik Ghosh (Cambridge, MA); Christopher Pirie (Cambridge, MA); Anthony Qualley (Cambridge, MA)
Assignee: Manus Bio Inc.
C12P7/26A01N27/00A23L27/13C12N9/0073C12P5/002C12Y114/13078A23V2002/00C07K2319/03
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,952,608
App. No.
17/141,758
Granted
Apr 9, 2024
Kind
B2
Abstract

The present invention relates to methods for producing oxygenated terpenoids. Polynucleotides, derivative enzymes, and host cells for use in such methods are also provided.

Claims (5)

1. A sesquiterpene oxidase comprising an amino acid sequence that has at least 80% sequence identity to the amino acid sequence SEQ ID NO: 37 or SEQ ID NO: 38, wherein the amino acid sequence of the sesquiterpene oxidase comprises a T499N substitution, and wherein the amino acid numbering corresponds to the amino acid sequence of SEQ ID NO: 37.

2. The sesquiterpene oxidase of claim 1 , wherein the amino acid sequence has at least 85% sequence identity to the amino acid sequence of SEQ ID NO: 37 or SEQ ID NO: 38.

3. The sesquiterpene oxidase of claim 1 , wherein the amino acid sequence has at least 90% sequence identity to the amino acid sequence of SEQ ID NO: 37 or SEQ ID NO: 38.

4. The sesquiterpene oxidase of claim 1 , wherein the amino acid sequence has at least 95% sequence identity to the amino acid sequence of SEQ ID NO: 37 or SEQ ID NO: 38.

5. The sesquiterpene oxidase of claim 1 , wherein the amino acid sequence of the sesquiterpene oxidase further comprises a F231L or F231I substitution, and wherein the amino acid numbering corresponds to the amino acid sequence of SEQ ID NO: 37.

Assignments (5)
SECURITY INTEREST Recorded Sep 8, 2025
From: MANUS BIO INC.; STO.PERU I LLC; STO.PERU II LLC; MANUS INTERMEDIATE INC.; MANUS INSCRIPTA, INC.
To: SYMBIOTIC CAPITAL AGENCY LLC, AS ADMINISTRATIVE AND COLLATERAL AGENT
Reel/Frame 072836/0255 →
RELEASE OF SECURITY INTEREST Recorded May 9, 2025
From: EICF AGENT LLC
To: MANUS BIO INC.
Reel/Frame 071247/0658 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 25, 2021
From: KUMARAN, AJIKUMAR PARAYIL; LIM, CHIN GIAW; LI, LIWEI; GHOSH, SOUVIK; PIRIE, CHRISTOPHER; QUALLEY, ANTHONY
To: MANUS BIOSYNTHESIS INC.
Reel/Frame 057892/0199 →
CHANGE OF NAME Recorded Oct 25, 2021
From: MANUS BIOSYNTHESIS, INC.
To: MANUS BIO INC.
Reel/Frame 058303/0334 →
SECURITY AGREEMENT Recorded Sep 14, 2021
From: MANUS BIO INC.
To: EICF AGENT LLC
Reel/Frame 057500/0058 →
Continuity (3)
Continuation 15505503
Provisional Application 62040284 · Aug 21, 2014
Related Publication 20210292798A1 · Sep 23, 2021